Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Inomax (nitric oxide) for Inhalation

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- August 2009

 

Summary View

 

WARNINGS AND PRECAUTIONS

Heart Failure
  • In patients with pre-existing left ventricular dysfunction, inhaled nitric oxide may increase pulmonary capillary wedge pressure leading to pulmonary edema.
  • Patients who had pre-existing left ventricular dysfunction treated with inhaled nitric oxide, even for
    short durations, experienced serious adverse events (e.g., pulmonary edema).

 

-
-